A detailed history of Royal Bank Of Canada transactions in Nutri Band Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 25 shares of NTRB stock, worth $150. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Previous 35,060 99.93%
Holding current value
$150
Previous $158,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$3.35 - $6.16 $117,367 - $215,815
-35,035 Reduced 99.93%
25 $0
Q1 2024

May 15, 2024

BUY
$2.3 - $4.52 $80,440 - $158,082
34,974 Added 40667.44%
35,060 $158,000
Q4 2023

Feb 14, 2024

SELL
$1.93 - $3.02 $67 - $105
-35 Reduced 28.93%
86 $0
Q3 2023

Nov 14, 2023

SELL
$2.38 - $4.63 $14 - $27
-6 Reduced 4.72%
121 $0
Q2 2023

Aug 14, 2023

BUY
$2.04 - $3.86 $259 - $490
127 New
127 $0
Q3 2022

Nov 14, 2022

BUY
$3.49 - $7.83 $293 - $657
84 New
84 $0

Others Institutions Holding NTRB

About NutriBand Inc.


  • Ticker NTRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,803,260
  • Market Cap $46.9M
  • Description
  • Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...
More about NTRB
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.